Skip to content
Screener

Pulse Biosciences, Inc. PLSE Manufacturing Costs

Manufacturing Costs at other companies

Luxfer Holdings logo
Luxfer HoldingsLXFR
$8.6M+3.6%
Luxfer Holdings logo
Luxfer HoldingsLXFR
$200K-33.3%
Flex Ltd. logo
Flex Ltd.FLEX
$695M+9.1%
Flex Ltd. logo
Flex Ltd.FLEX
$758M+10.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$9.09M-39.2%
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
$3.2M+8.8%

Segments

By segment

See full
Single Reportable$3.2M+8.8%

Other financials

Income statement

See full
Revenue$434.0K—
Gross profit$161.0K—
Operating income-$25.3M-24.6%
Net income-$24.7M-28.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$101.6M-4.4%
Total debt$6.8M-17.9%
Total equity$99.5M-4.8%
Total assets$115.6M-3.9%

Cash flow

See full
Operating cash flow-$18.7M-46.1%
CapEx$90.0K-12.6%
Free cash flow-$18.8M-45.6%

Valuation

See full
Market cap$2.65B+202%
Enterprise value$2.55B+224%
P/S2,233.4×—

Profitability

See full
Gross margin-0.1%—
Operating margin-7,007.8%—
Net margin-6,755.8%—
FCF margin-5,180.4%—

Returns & leverage

See full
Return on equity-78.5%-15.3pp
Debt / equity0.1×0.0×
Current ratio9.6×-2.4×